Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Critical Reviews in Oncology/Hematology|September 4, 2007
The impact of acute myeloid leukemia and its treatment on quality of life and functional status in older adultsShabbir M H Alibhai, Marc Leach, Husnain Kermalli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 15, 2024
Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal modelsAysha S Ansari, Remant K C, Luis C Morales, et al.
Leukemia & Lymphoma|October 16, 2012
A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186David A Macdonald, Sarit E Assouline, Joseph Brandwein, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 24, 2020
Day 14 Bone Marrow Evaluation During Acute Myeloid Leukemia Induction in a Real-world Canadian CohortJames T England, Lalit Saini, Donna Hogge, et al.
Leukemia & Lymphoma|May 27, 2004
Clinico-biological features and prognostic significance of PML/RARalpha isoforms in adult patients with acute promyelocytic leukemia treated with all trans retinoic acid (ATRA) and chemotherapyVikas Gupta, Qi-Long Yib, Joseph Brandwein, et al.
Journal for Immunotherapy of Cancer|May 1, 2021
Expanded antigen-experienced CD160<sup>+</sup>CD8<sup>+</sup>effector T cells exhibit impaired effector functions in chronic lymphocytic leukemiaNajmeh Bozorgmehr, Isobel Okoye, Olaide Oyegbami, et al.
Biomolecules|January 25, 2025
Lipopolymers as the Basis of Non-Viral Delivery of Therapeutic siRNA Nanoparticles in a Leukemia (MOLM-13) ModelPanadda Yotsomnuk, Amarnath Praphakar Rajendran, Daniel Nisakar Meenakshi Sundaram, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 12, 2012
A phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignanciesAaron D Schimmer, Yulia Jitkova, Marcela Gronda, et al.
European Journal of Haematology|March 31, 2016
The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac diseaseLalit Saini, Joseph Brandwein, Robert Turner, et al.
Leukemia & Lymphoma|January 30, 2010
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group StudyMichael Crump, David Hedley, Suzanne Kamel-Reid, et al.
Pageof 8